BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Eventin//Event Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:6704b565c592266746078f3a97d14a91@uk-icn.co.uk
SUMMARY:2023 September Virtual Seminar
DESCRIPTION:Chair: Professor Julian Hiscox\, University of Liverpool and UK
 -ICN Director\n\nDr Giada Mattiuzzo\, Medicines and Healthcare products Reg
 ulatory Agency (MHRA) - Standardisation of COVID-19 serological assays: too
 ls and challenges\n\nGiada is leading the Viral Vaccines group at the Medic
 ines and Healthcare products Regulatory Agency (MHRA). She joined the Agenc
 y\, formerly known as  NIBSC\, in 2010 after being awarded a PhD in Molecu
 lar Virology by University College London. Her research interests focus on 
 assay development and standardization for emerging viruses and viral vaccin
 es. She is the project leader for the development World Health Organization
  (WHO) International Standards projects on several emerging viruses\, inclu
 ding SARS-CoV-2\, MERS-CoV\, Rift Valley fever Virus\, Lassa virus and Mpox
 .\n\nDr Neil Almond\, Medicines and Healthcare products Regulatory Agency (
 MHRA) - Applying animal models to dissect correlations of protection agains
 t SARS-CoV-2\n\nNeil has been working at NIBSC and now MHRA South Mimms Lab
 oratories since 1988\, when he was appointed with short term funding from t
 he MRC’s AIDS Directed Programme.  He worked on and subsequently led the
  programme to develop and apply simian models of HIV/AIDS to establish a sc
 ientific framework for the development of safe and effective vaccines for H
 IV/AIDS.  Over the past 10 years with the emergence/re-emergence of new vi
 ruses\, he has worked with colleagues at MHRA-SML\, UKHSA and Dstl to estab
 lish models of infection to establish the role of serological responses in 
 protection to inform vaccine development\, including Zika\, CHIKV and most 
 recently SARS-CoV-2\, which will be the focus of his talk.
LOCATION:Online
DTSTAMP:20260609T200744Z
DTSTART:20230928T080000Z
DTEND:20260609T090000Z
END:VEVENT
END:VCALENDAR